Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Point-of-Care Testing: Page 2
Missed cancer screenings continue during pandemic’s second year
The COVID-19 pandemic disrupted the delivery and receipt of many routine preventive services, including important cancer screenings that might help prevent and catch cancer at its earliest stages, when it is often easiest to treat.
February 24, 2023
Maternova, MedMira ink agreement to market rapid diagnostic tests for HIV, syphilis, hepatitis
MedMira's Multiplo TP/HIV rapid test delivers 100% sensitivity in identifying co-infections and is helping to reduce mother-to-child transmission of syphilis and HIV, the firms said.
February 21, 2023
Ingestible ‘smart pill’ may pinpoint GI disorders
An ingestible smart pill uses magnetic fields to track its movement through the GI tract, potentially facilitating the treatment of GI motility disorders.
February 13, 2023
QuidelOrtho anticipates $2.8B to $3.1B in 2023 revenue, sees COVID-19 as another seasonal virus
The firm is seeing greater access to semiconductor chips and expects inflation and supply chain challenges to further ease as this year progresses, said its CFO Joseph Busky.
February 16, 2023
FDA grants emergency use authorization for Anavasi LAMP-based COVID-19 test, detector
Anavasi said its point-of-care platform will enable the rapid development of tests to detect viral and bacterial targets, including influenza, respiratory syncytial virus (RSV), and sexual health-related strains, among others.
February 13, 2023
AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device
Capitainer's quantitative self-sampling product automatically separates cells from whole blood using a finger stick that can be done in a patient's home, potentially expanding access to individuals who would participate in clinical trials.
February 1, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Beckman Coulter, MeMed collaborate to expand adoption of host immune response diagnostic test
MeMed developed its BV test to address the management of patients with acute infection in different clinical settings, including emergency departments, and distinguish between bacterial and viral infections early in the diagnostic process.
January 31, 2023
Jana Care, Roche to develop blood-testing platform for chronic kidney and heart disease
The platform would enable patients to self-administer critical blood tests at home, and allow clinicians to review the test results remotely.
January 31, 2023
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Each diagnostic company specializes in the development, manufacturing, and marketing of point-of-care diagnostic tests for the professional and at-home markets.
February 1, 2023
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
The acquisition enables Sherlock to combine its CRISPR, synthetic biology, and artificial intelligence technologies with Sense's instrument-free diagnostic hardware and rapid molecular amplification chemistries.
February 1, 2023
Vision Research supplies high-speed camera for Cytovale point-of-care sepsis test
An enabling technology for flow cytometry, the Vision Research Phantom VEO 710 high-speed camera resolves blood cells as they move through a microfluidics channel at three meters per second.
January 30, 2023
EMR screening program identifies prevalent undiagnosed diabetes
A published study underscored long-existing disparities in type 2 diabetes diagnosis and treatment by race, ethnicity, and socioeconomic factors. Such disparities increased during the COVID-19 pandemic.
January 27, 2023
Previous Page
Page 2 of 36
Next Page